Dinesh Kumar Chellappan

InstitutionInternational Medical University
AddressMalaysia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 3 publications in June 2021 and July 2021
    All Publications
    Bar chart showing 67 publications over 11 distinct years, with a maximum of 20 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gupta G, S R, Singh Y, Thangavelu L, Singh SK, Dureja H, Chellappan DK, Dua K. Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics. Drug Dev Res. 2021 11; 82(7):880-882. PMID: 34323298.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    2. Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul; 7(7):e07635. PMID: 34312598.
      Citations: 1     
    3. Chong WC, Chellappan DK, Shukla SD, Peterson GM, Patel RP, Jha NK, Eri RD, Dua K, Tambuwala MM, Shastri MD. An Appraisal of the Current Scenario in Vaccine Research for COVID-19. Viruses. 2021 07 18; 13(7). PMID: 34372603.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, Thangavelu L, Singh SK, Rama Raju Allam VS, Jha NK, Chellappan DK, Dua K, Gupta G. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021 Aug 25; 345:109568. PMID: 34181887.
      Citations: 3     Fields:    Translation:HumansAnimals
    5. Chan Y, Ng SW, Singh SK, Gulati M, Gupta G, Chaudhary SK, Hing GB, Collet T, MacLoughlin R, Löbenberg R, Oliver BG, Chellappan DK, Dua K. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci. 2021 Sep 01; 280:119744. PMID: 34174324.
      Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    6. Alnuqaydan AM, Almutary AG, Sukamaran A, Yang BTW, Lee XT, Lim WX, Ng YM, Ibrahim R, Darmarajan T, Nanjappan S, Chellian J, Candasamy M, Madheswaran T, Sharma A, Dureja H, Prasher P, Verma N, Kumar D, Palaniveloo K, Bisht D, Gupta G, Madan JR, Singh SK, Jha NK, Dua K, Chellappan DK. Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech. 2021 Jun 08; 22(5):173. PMID: 34105037.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    7. Anand K, Vadivalagan C, Joseph JS, Singh SK, Gulati M, Shahbaaz M, Abdellattif MH, Prasher P, Gupta G, Chellappan DK, Dua K. A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact. 2021 Aug 01; 344:109497. PMID: 33991505.
      Citations:    Fields:    Translation:HumansCells
    8. Bisht D, Kumar D, Kumar D, Dua K, Chellappan DK. Phytochemistry and pharmacological activity of the genus artemisia. Arch Pharm Res. 2021 May; 44(5):439-474. PMID: 33893998.
      Citations:    Fields:    Translation:HumansAnimals
    9. Singh Y, Ali H, Alharbi KS, Almalki WH, Kazmi I, Al-Abbasi FA, Anand K, Dureja H, Singh SK, Thangavelu L, Chellappan DK, Dua K, Gupta G. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Dev Res. 2021 09; 82(6):784-788. PMID: 33687087.
      Citations:    Fields:    Translation:Humans
    10. Shahcheraghi SH, Ayatollahi J, Aljabali AA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M, Satija S, Dureja H, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Gupta G, Dua K, Lotfi M, Bakshi HA, Tambuwala MM. An overview of vaccine development for COVID-19. Ther Deliv. 2021 03; 12(3):235-244. PMID: 33624533.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    11. Sunkara K, Allam VR, Shukla SD, Chellappan DK, Gupta G, MacLoughlin R, Dua K. COVID-19 in underlying COPD Patients. EXCLI J. 2021; 20:248-251. PMID: 33628161.
      Citations:    
    12. Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209. PMID: 33464535.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    13. Mehta M, Prasher P, Sharma M, Shastri MD, Khurana N, Vyas M, Dureja H, Gupta G, Anand K, Satija S, Chellappan DK, Dua K. Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis. Med Hypotheses. 2020 Nov; 144:110254. PMID: 33254559.
      Citations: 4     Fields:    Translation:Humans
    14. Prasher P, Sharma M, Gupta G, Chellappan DK, Dua K. Are Medicinal Plants an Alternative Strategy to Combat COVID-19? Altern Ther Health Med. 2020 Aug; 26(S2):92-93. PMID: 32827405.
      Citations:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    15. Singh Y, Gupta G, Mishra A, Chellappan DK, Dua K. Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak. Altern Ther Health Med. 2020 Aug; 26(S2):54-55. PMID: 32412919.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    16. Sharma M, Prasher P, Mehta M, Zacconi FC, Singh Y, Kapoor DN, Dureja H, Pardhi DM, Tambuwala MM, Gupta G, Chellappan DK, Dua K, Satija S. Probing 3CL protease: Rationally designed chemical moieties for COVID-19. Drug Dev Res. 2020 Jul 30. PMID: 32729640.
      Citations: 3     Fields:    
    17. Singh Y, Gupta G, Kazmi I, Al-Abbasi FA, Negi P, Chellappan DK, Dua K. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol Ther. 2020 11; 33(6):e13871. PMID: 32558055.
      Citations: 13     Fields:    Translation:Humans
    18. Satija S, Mehta M, Sharma M, Prasher P, Gupta G, Chellappan DK, Dua K. Vesicular drug delivery systems as theranostics in COVID-19. Future Med Chem. 2020 09; 12(18):1607-1609. PMID: 32589055.
      Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    19. Singh Y, Gupta G, Satija S, Negi P, Chellappan DK, Dua K. RAAS blockers in hypertension posing a higher risk toward the COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13501. PMID: 32359088.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    20. Singh Y, Gupta G, Satija S, Pabreja K, Chellappan DK, Dua K. COVID-19 transmission through host cell directed network of GPCR. Drug Dev Res. 2020 09; 81(6):647-649. PMID: 32329083.
      Citations: 10     Fields:    Translation:HumansAnimalsPHPublic Health
    21. Aljabali AAA, Bakshi HA, Satija S, Metha M, Prasher P, Ennab RM, Chellappan DK, Gupta G, Negi P, Goyal R, Sharma A, Mishra V, Dureja H, Dua K, Tambuwala MM. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. Pharm Nanotechnol. 2020; 8(4):323-353. PMID: 32811406.
      Citations: 3     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Chellappan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (282)
    Explore
    _
    Co-Authors (124)
    Explore
    _
    Similar People (60)
    Explore
    _